Deal Announcements

Metabolex Lands New Venture Capital Investment

Tuesday, November 10, 2009 5:34:00 AM PDT | VentureDeal Staff

Hayward, California  --  Pharmaceutical company Metabolex has raised $8.6 million in a new round of venture capital financing.

Metabolex says that is "dedicated to the discovery and development of drugs to treat diabetes and related metabolic disorders."

Investors in the round included Alta Partners, Venrock, Versant Ventures, Bay City Capital and others.  The company said it would use the funding to continue to advance its potential new therapy for treating type II diabetes.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin

PCI - Level1